Bruce J. Dezube

Bruce J. Dezube publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bruce J. Dezube sits on this spectrum.

Bruce J. Dezube D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bruce J. Dezube sits on this spectrum.

Best Publications

• Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

  Eunice L. Kwak;Yung-Jue Bang;D. Ross Camidge;Alice T. Shaw

  5280
  Citations

• Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

  D W Northfelt;B J Dezube;J A Thommes;B J Miller

  774
  Citations

• Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

  Gerd Fätkenheuer;Anton L Pozniak;Margaret A Johnson;Andreas Plettenberg

  659
  Citations

• Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

  John C. Morris;Antoinette R. Tan;Thomas E. Olencki;Geoffrey I. Shapiro

  577
  Citations

• Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.

  Young Kwon Hong;Kimberly Foreman;Jay W. Shin;Satoshi Hirakawa

  467
  Citations

• Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

  Simon Stewart;Helmut Jablonowski;Franc D. Goebel;Keikawus Arasteh

  465
  Citations

• Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

  Panagiotis A. Konstantinopoulos;Steven Waggoner;Gregory A. Vidal;Monica Mita

  434
  Citations

• Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

  Lawrence D. Kaplan;David J. Straus;Marcia A. Testa;Jamie Von Roenn

  419
  Citations

• Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.

  Shaveta Vinayak;Shaveta Vinayak;Sara M. Tolaney;Lee Schwartzberg;Monica Mita

  364
  Citations

• HIV-associated plasmablastic lymphoma: Lessons learned from 112 published cases

  Jorge Castillo;Liron Pantanowitz;Bruce J. Dezube

  353
  Citations

• Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

  Chiang J. Li;Lin J. Zhang;Bruce J. Dezube;Clyde S. Crumpacker

  310
  Citations

• The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.

  Lisa L. Decker;Premalata Shankar;Gulfaraz Khan;Richard B. Freeman

  305
  Citations

• Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

  Joseph A. Sparano;Jeannette Y. Lee;Lawrence D. Kaplan;Alexandra M. Levine

  302
  Citations

• Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study

  Ronan T. Swords;Harry P. Erba;Daniel J. Deangelo;Dale L. Bixby

  286
  Citations

• The rising challenge of non-AIDS-defining cancers in HIV-infected patients

  John F. Deeken;Angelique Tjen-A-Looi;Michelle A. Rudek;Catherine Okuliar

  276
  Citations

• A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas

  David S. Hong;Razelle Kurzrock;Jeffrey G. Supko;Xiaoying He

  254
  Citations

• AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy

  Matthew C. Cheung;Liron Pantanowitz;Bruce J. Dezube

  242
  Citations

• Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.

  Anniina Färkkilä;Doga C. Gulhan;Julia Casado;Connor A. Jacobson

  229
  Citations

• Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma—Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease

  Ryan J. Sullivan;Liron Pantanowitz;Corey Casper;Corey Casper;Justin Stebbing

  215
  Citations

• Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma

  Henry B. Koon;Glenn J. Bubley;Liron Pantanowitz;David Masiello

  212
  Citations